GSGalina Yu. Startseva

Galina Yu. Startseva

*This is an algorithmically generated author record based on publicly available information.

Galina Yu. Startseva has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Varicella (chickenpox) has “matured” and become even more dangerous

    by Vladimir A. Neverov, Galina I. Kirpichnikova, Vsevolod M. Antonov, Galina Yu. Startseva, Margarita V. Klur

    This lecture focuses on varicella (chickenpox), one of the highly contagious diseases, the outbreaks of which can be effectively prevented through vaccination. It highlights modern aspects of the etiology, pathogenesis, epidemiology, clinical presentation, diagnosis, treatment, and prevention of varicella. Additionally, the lecture explores the clinical diversity of the disease’s forms and complications, including cases in newborns with perinatal infection. Compelling evidence characterizes varicella as a severe and “non-benign” infectious disease, which ranks among the leading causes of economic losses associated with infectious diseases in Russia. The “maturation” of varicella observed in recent years has led to serious consequences, including more severe complications in adults compared to children, an increased economic burden, and a rising number of cases among pregnant women, resulting in higher rates of congenital and neonatal varicella. In light of increasing varicella incidence in Russia and several other countries, the data presented in this lecture are particularly valuable for practicing physicians, especially family doctors.

  • Open Access

    Clinical and laboratory characteristics of patients with severe COVID-19 undergoing gene engineering therapy

    by Aleksandra V. Rogozhkina, Margarita N. Pogromskaya, Elena S. Romanova, Galina Yu. Startseva, Olga M. Filipovich, Margarita V. Klur, Vsevolod M. Antonov

    Background: One of the primary factors contributing to an increased risk of fatal outcomes in severe COVID-19 cases is the development of a cytokine storm, a hyperimmune response characterized by excessive cytokine release. Despite using biologic therapies, mortality rates in severe COVID-19 cases remain significantly high. Aim: To analyze and evaluate the clinical and laboratory parameters of patients with severe COVID-19 who received biologic therapy. Materials and methods: A cluster sampling method was employed, with clusters selected based on the severity of the primary disease and biologic therapy. The study included 65 patients, divided into two groups based on disease outcomes: Group 1 comprised 34 patients with favorable outcomes, while Group 2 included 31 patients with fatal outcomes. Results: Significant differences were observed between the groups in terms of age (p = 0.01). Patients in Group 2 (with fatal outcomes) had a higher burden of co-morbidities, as measured by the Charlson Comorbidity Index (p = 0.00009) and the Cumulative Illness Rating Scale for Geriatrics (CIRS-G; p = 0.000003). Additionally, the groups differed significantly in the number of days from disease onset to the initiation of biologic therapy (p = 0.02). In Group 2, delayed initiation of biologic therapy was associated with persistently high concentrations of acute-phase proteins. Conclusions: Key factors influencing the efficacy of biologic therapy for severe COVID-19 with cytokine storm include patient age, the presence and severity of co-morbidities, and the timing of hospitalization and initiation of biologic therapy.

  • Open Access

    Pertussis is still not a completely controlled infection

    by Vladimir A. Neverov, Galina I. Kirpichnikova, Vsevolod M. Antonov, Galina Yu. Startseva, Margarita V. Klur

    The lecture focuses on pertussis, an infection managed by specific preventive measures, which continues to threaten both child and maternal health, as well as overall healthcare system. Despite high vaccination rates, pertussis remains an “under-controlled” infection and a significant contributor to childhood morbidity and mortality. Moreover, in many countries, the incidence of pertussis is clearly rising among both children and adults, with a notable proportion of cases occurring in vaccinated individuals. This increase may be associated with changes in the antigenic structure of the pathogen, the limited duration of post-vaccination immunity, reduced vaccination coverage, and the use of more sensitive laboratory diagnostic methods. The lecture addresses modern aspects of the etiopathogenesis, epidemiology, clinical presentation, diagnosis, treatment, and prevention of pertussis. Given the rising incidence of this infection in Russia and several other countries in 2023, the information presented will be especially valuable for practitioners, particularly family doctors.

  • Measles and rubella are two controlled airborne infections: etiopathogenesis, epidemiology, clinical picture, diagnosis, treatment and prevention. Part 2. Rubella

    by Vladimir A. Neverov, Galina I. Kirpichnikova, Vsevolod M. Antonov, Galina Yu. Startseva, Margarita V. Klur

    The lecture is devoted to two infections controlled by specific means of prevention — measles and rubella, which still pose a danger both to the sphere of child and maternal health, and to healthcare in general. The second part of the lecture is devoted to rubella, which, despite its benign course in most cases, currently poses a serious problem for global health due to its ubiquity and high incidence of severe intrauterine lesions of the fetus. Despite significant advances in the field of diagnosis and immunoprophylaxis of rubella, it is still found in economically developed countries with confirmed elimination of the disease. Therefore, to prevent the return of this infection to our country, where its elimination was achieved by 2018, maximum coverage of the population with vaccinations against rubella is still necessary in all its regions. The lecture covers modern aspects of the etiopathogenesis, epidemiology, clinical picture, diagnosis, treatment and prevention of rubella. This information, given the increasing incidence of rubella, even in countries with confirmed elimination of the disease, may be useful for general practitioners, primarily family doctors.

  • Measles and rubella are two controlled airborne infections: etiopathogenesis, epidemiology, clinical picture, diagnosis, treatment and prevention. Part 1. Measles

    by Vladimir A. Neverov, Galina I. Kirpichnikova, Vsevolod M. Antonov, Galina Yu. Startseva, Margarita V. Klur

    The lecture is devoted to two infections controlled by specific means of prevention — measles and rubella, which still pose a danger both to the sphere of child and maternal health, and to healthcare in general. The first part of the lecture is devoted to measles, one of the most contagious diseases, outbreaks of which can be successfully prevented through vaccination or, conversely, serve as an indicator of gaps in immunization programs and primary health care systems. The lecture covers modern aspects of etiopathogenesis, epidemiology, clinical picture, diagnosis, treatment and prevention of measles. In the context of an increase in the incidence of this infection in our country and a number of foreign countries in 2023, the information presented in the lecture may be useful for practitioners and, first of all, family doctors.

  • Open Access

    Acute iucterine hepatitis as a manifestation of severe autoimmune hepatitis

    by Nikolai I. Kuznetsov, Valery V. Vasiliev, Elena S. Romanova, Galina Yu. Startseva, Ivan P. Fedunyak, Vladimir B. Musatov, Alexander М. Alekseev, Васильев Валерий Викторович

    In the article, on the example of a clinical case, a variant of the course of severe acute autoimmune hepatitis type II in a 20-year-old woman is analyzed. The prevalence of this disease are presented. Possible types of autoimmune hepatitis course are discussed. The main diagnostic criteria that indicate the likelihood of autoimmune hepatitis and the tactics of managing these patients are described. This clinical case demonstrates that in the absence of epidemiological, anamnestic data indicating a possible viral or toxic liver damage, it is necessary to think and exclude autoimmune liver damage. It is believed that the level of gamma globulin exceeding more than 1.5 times the upper limit of normal and the absence of viral hepatitis are independent predictors of the presence of autoimmune hepatitis, and the earlier immunosuppressive therapy is started, the more favorable the prognosis of the disease.

  • Open Access

    The problem of toxoplasmosis in outpatient practice. Part I. Toxoplasmosis in immunocompetent patients

    by Valerii V. Vasiliev, Nikolai I. Kuznetsov, Galina Yu. Startseva, Васильев Валерий Викторович

    Acute toxoplasmosis in immunocompetent persons most often proceeds subclinically and ends with the formation of latent toxoplasmosis, which does not require therapy and observation. The presence of clinical signs of a long-term disease forces an extensive diagnostic search to exclude/confirm chronic toxoplasmosis. In the treatment of toxoplasmosis in persons without immunodeficiency, repeated courses of antiprotozoal drugs are used, which do not guarantee clinical recovery and the absence of relapses. Perinatal aspects of toxoplasmosis will be discussed in a future publication.